Holen Sie sich die Stockscreener-App
1.49
6.29%
-0.10
Handel nachbörslich:
1.53
0.04
+2.68%
Schlusskurs vom Vortag:
$1.59
Offen:
$1.55
24-Stunden-Volumen:
3.75M
Relative Volume:
0.94
Marktkapitalisierung:
$465.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.08M
KGV:
-5.5185
EPS:
-0.27
Netto-Cashflow:
$-72.53M
1W Leistung:
+10.37%
1M Leistung:
+24.17%
6M Leistung:
+41.90%
1J Leistung:
+79.32%
1-Tages-Spanne:
$1.49
$1.57
1-Wochen-Bereich:
$1.32
$1.65
52-Wochen-Spanne:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Firmenname
Ocugen Inc
Sektor
Branche
Telefon
484-328-4701
Adresse
11 GREAT VALLEY PARKWAY, MALVERN, PA
Vergleichen Sie OCGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.49 | 496.59M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-15 | Eingeleitet | Maxim Group | Buy |
| 2023-03-01 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Eingeleitet | Mizuho | Buy |
| 2022-06-15 | Fortgesetzt | ROTH Capital | Buy |
| 2022-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-06-11 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Alle ansehen
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
Can Ocugen Inc. (2H51) stock sustain revenue momentumWeekly Trading Summary & Free Technical Pattern Based Buy Signals - ulpravda.ru
Ocugen Inc Is Exploding Again: Hidden Gem or Total Meme Stock? - AD HOC NEWS
Can Ocugen Inc. stock withstand economic slowdownSector Performance Review & Low Risk Wealth Plans - ulpravda.ru
Ocugen Shares Surge Ahead of Pivotal Clinical Data Release - AD HOC NEWS
Ocugen’s Pivotal Year: Clinical Milestones and Financial Runway Define 2026 Outlook - AD HOC NEWS
Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments - Seeking Alpha
Could Ocugen Offer A Vision Of Growth With 2026 Catalysts Approaching? - RTTNews
Ocugen Shares Face Pressure Following Strong Advance - AD HOC NEWS
Ocugen’s OCU400 Receives ATMP Classification from European Commission, Advancing Retinitis Pigmentosa Treatment - MSN
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
Market Outlook: Can Pharmaron Beijing Co Ltd 17Q1 stock expand revenue streamsQuarterly Investment Review & Expert Approved Momentum Trade Ideas - moha.gov.vn
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Ocugen’s Pivotal Year: Clinical Data and Financial Runway in Focus - AD HOC NEWS
Ocugen stock surges 75% year to date: What's in store for 2026? - MSN
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Ocugen’s Gene Therapy Pipeline Drives Investor Optimism - AD HOC NEWS
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026? - The Globe and Mail
Ocugen Shares Test Critical Technical Floor - AD HOC NEWS
Ocugen Sees Unusually High Options Volume (NASDAQ:OCGN) - MarketBeat
Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch
Ocugen Shares Navigate Year-End Consolidation Phase - AD HOC NEWS
Ocugen Inc. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Ocugen’s Pipeline Progress: Targeting Unmet Needs in Rare Eye Diseases - AD HOC NEWS
Is Ocugen’s (OCGN) Rare Disease Summit Spotlight Reframing Its Gene Therapy Investment Narrative? - Yahoo Finance
Is Ocugen (OCGN) Quietly Reframing Its Risk Profile Around Rare Disease Gene Therapies? - simplywall.st
Why Ocugen Inc. stock is a must watch in 2025Energy Sector Updates & Achieve Triple Digit Returns - bollywoodhelpline.com
Why Ocugen Inc. (2H51) stock stays on top picksOptions Play & Community Verified Trade Signals - Улправда
Can Ocugen Inc. stock weather global recession2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru
Bear Alert: Can Ocugen Inc. stock weather global recessionJuly 2025 Weekly Recap & Risk Managed Investment Strategies - Улправда
Will Ocugen Inc. stock deliver strong dividend growth2025 Macro Impact & Verified Trade Idea Suggestions - Улправда
Ocugen Ties CEO Compensation to Regulatory and Stock Performance - AD HOC NEWS
Is Ocugen Inc. (2H51) stock dividend growth reliable2025 Trading Volume Trends & Technical Entry and Exit Tips - DonanımHaber
Why Ocugen Inc. (2H51) stock is listed among top recommendationsMarket Performance Summary & Weekly Consistent Profit Watchlists - DonanımHaber
Will Ocugen Inc. stock maintain growth story2025 Risk Factors & Low Drawdown Trading Strategies - DonanımHaber
Ocugen Inc. stock falls Friday, underperforms market - MarketWatch
Ocugen Grants CEO New Performance-Based Equity Award - TipRanks
Pharma News: Why Ocugen Inc. stock is a must watch in 2025July 2025 Summary & Risk Adjusted Buy and Sell Alerts - Улправда
Why pension funds invest in Ocugen Inc. (2H51) stockAnalyst Upgrade & Safe Entry Trade Reports - Улправда
Ocugen Shares Face Mounting Pressure Amid Financial Concerns - AD HOC NEWS
Ocugen Inc. Stock Rises Tuesday, Outperforms Market - 富途牛牛
Ocugen Inc. Stock Rises Monday, Outperforms Market - 富途牛牛
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - Nasdaq
Ocugen (NASDAQ:OCGN) Shares Up 1.5%What's Next? - MarketBeat
How The Latest Analyst Shifts Are Reshaping Ocugen’s Story and Valuation - Yahoo Finance
Ocugen Inc Stock Analysis and ForecastSector Rotation Strategies & Free Rapid Growing Investment Returns - earlytimes.in
Growth Recap: Is Ocugen Inc stock supported by strong cash flowsJuly 2025 Review & Stepwise Trade Execution Plans - moha.gov.vn
Institutional Giant Janus Henderson Makes Major Bet on Ocugen - AD HOC NEWS
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Ocugen I - GuruFocus
Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch
Ocugen CEO’s Keynote Address Meets Heightened Market Skepticism - Ad-hoc-news.de
Finanzdaten der Ocugen Inc-Aktie (OCGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):